Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Combinatorial ligand-directed lung targeting.

Giordano RJ, Edwards JK, Tuder RM, Arap W, Pasqualini R.

Proc Am Thorac Soc. 2009 Aug 15;6(5):411-5. doi: 10.1513/pats.200903-014AW.

2.

From combinatorial chemistry to cancer-targeting peptides.

Aina OH, Liu R, Sutcliffe JL, Marik J, Pan CX, Lam KS.

Mol Pharm. 2007 Sep-Oct;4(5):631-51. Epub 2007 Sep 20. Review.

PMID:
17880166
3.

In vivo phage display and vascular heterogeneity: implications for targeted medicine.

Trepel M, Arap W, Pasqualini R.

Curr Opin Chem Biol. 2002 Jun;6(3):399-404. Review.

PMID:
12023122
4.

Vascular targeting with phage peptide libraries.

Pasqualini R.

Q J Nucl Med. 1999 Jun;43(2):159-62. Review.

PMID:
10429511
5.

Molecular addresses of tumors: selection by in vivo phage display.

Li XB, Schluesener HJ, Xu SQ.

Arch Immunol Ther Exp (Warsz). 2006 May-Jun;54(3):177-81. Epub 2006 May 31. Review.

PMID:
16736105
6.

Novel challenges in exploring peptide ligands and corresponding tissue-specific endothelial receptors.

Balestrieri ML, Napoli C.

Eur J Cancer. 2007 May;43(8):1242-50. Epub 2007 Apr 20. Review.

PMID:
17449238
7.

Phage peptide display.

Newton J, Deutscher SL.

Handb Exp Pharmacol. 2008;(185 Pt 2):145-63. doi: 10.1007/978-3-540-77496-9_7. Review.

PMID:
18626602
8.

Phenotypic diversity of the lung vasculature in experimental models of metastases.

Oh Y, Mohiuddin I, Sun Y, Putnam JB Jr, Hong WK, Arap W, Pasqualini R.

Chest. 2005 Dec;128(6 Suppl):596S-600S. Review.

PMID:
16373855
9.

Combinatorial vascular targeting in translational medicine.

Staquicini FI, Moeller BJ, Arap W, Pasqualini R.

Proteomics Clin Appl. 2010 Jul;4(6-7):626-32. doi: 10.1002/prca.200900213. Epub 2010 Mar 24. Review.

PMID:
21137081
10.

Mapping tumor vascular diversity by screening phage display libraries.

Zurita AJ, Arap W, Pasqualini R.

J Control Release. 2003 Aug 28;91(1-2):183-6. Review.

PMID:
12932650
11.

Vascular targeting: recent advances and therapeutic perspectives.

Hajitou A, Pasqualini R, Arap W.

Trends Cardiovasc Med. 2006 Apr;16(3):80-8. Review.

PMID:
16546688
12.

Vascular-homing peptides for targeted drug delivery and molecular imaging: meeting the clinical challenges.

D'Onofrio N, Caraglia M, Grimaldi A, Marfella R, Servillo L, Paolisso G, Balestrieri ML.

Biochim Biophys Acta. 2014 Aug;1846(1):1-12. doi: 10.1016/j.bbcan.2014.03.004. Epub 2014 Apr 1. Review.

PMID:
24704283
13.

Targeting tumor vasculature with homing peptides from phage display.

Ruoslahti E.

Semin Cancer Biol. 2000 Dec;10(6):435-42. Review.

PMID:
11170865
14.

Cancer-specific ligands identified from screening of peptide-display libraries.

Mori T.

Curr Pharm Des. 2004;10(19):2335-43. Review.

PMID:
15279612
15.

Identification of receptor ligands with phage display peptide libraries.

Koivunen E, Arap W, Rajotte D, Lahdenranta J, Pasqualini R.

J Nucl Med. 1999 May;40(5):883-8. Review.

16.

In vivo phage display--a discovery tool in molecular biomedicine.

Bábíčková J, Tóthová Ľ, Boor P, Celec P.

Biotechnol Adv. 2013 Dec;31(8):1247-59. doi: 10.1016/j.biotechadv.2013.04.004. Epub 2013 Apr 23. Review.

PMID:
23623852
17.

Vascular zip codes in angiogenesis and metastasis.

Ruoslahti E.

Biochem Soc Trans. 2004 Jun;32(Pt3):397-402. Review.

PMID:
15157146
18.

Peptide targeting of tumor lymph vessels.

Laakkonen P, Zhang L, Ruoslahti E.

Ann N Y Acad Sci. 2008;1131:37-43. doi: 10.1196/annals.1413.003. Review.

PMID:
18519957
19.

Molecular addresses in blood vessels as targets for therapy.

Kolonin M, Pasqualini R, Arap W.

Curr Opin Chem Biol. 2001 Jun;5(3):308-13. Review.

PMID:
11479123
20.

Protein-protein interactions in hematology and phage display.

Mullaney BP, Pallavicini MG.

Exp Hematol. 2001 Oct;29(10):1136-46. Review.

PMID:
11602315
Items per page

Supplemental Content

Write to the Help Desk